Evidence map›Paper›PMID 36990978›Full record

ArticleNature communications2023

MS2Query: reliable and scalable MS

Niek F de Jonge, Joris J R Louwen, Elena Chekmeneva, Stephane Camuzeaux, Femke J Vermeir, Robert S Jansen, Florian Huber, Justin J J van der Hooft

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. LC-MS Data Processing Using OpenMS.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Niek F de JongeBioinformatics Group, Wageningen University & Research, 6708 PB, Wageningen, the Netherlands. niek.dejonge@wur.nl.ORCID 0000-0002-3054-6210
Joris J R LouwenBioinformatics Group, Wageningen University & Research, 6708 PB, Wageningen, the Netherlands.
Elena ChekmenevaNational Phenome Centre, Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, W12 0NN, UK.ORCID 0000-0003-1807-2398
Stephane CamuzeauxNational Phenome Centre, Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, W12 0NN, UK.ORCID 0000-0002-4614-4662
Femke J VermeirDepartment of Microbiology, Radboud Institute for Biological and Environmental Sciences, Radboud University, 6525ED, Nijmegen, the Netherlands.
Robert S JansenDepartment of Microbiology, Radboud Institute for Biological and Environmental Sciences, Radboud University, 6525ED, Nijmegen, the Netherlands.ORCID 0000-0001-9612-2798
Florian HuberCentre for Digitalization and Digitality (ZDD), University of Applied Sciences Düsseldorf, Düsseldorf, Germany. florian.huber@hs-duesseldorf.de.ORCID 0000-0002-3535-9406
Justin J J van der HooftBioinformatics Group, Wageningen University & Research, 6708 PB, Wageningen, the Netherlands. justin.vanderhooft@wur.nl.ORCID 0000-0002-9340-5511

Funding

Medical Research Council MR/S010483/1
6 · The paper itself

Abstract

Metabolomics-driven discoveries of biological samples remain hampered by the grand challenge of metabolite annotation and identification. Only few metabolites have an annotated spectrum in spectral libraries; hence, searching only for exact library matches generally returns a few hits. An attractive alternative is searching for so-called analogues as a starting point for structural annotations; analogues are library molecules which are not exact matches but display a high chemical similarity. However, current analogue search implementations are not yet very reliable and relatively slow. Here, we present MS2Query, a machine learning-based tool that integrates mass spectral embedding-based chemical similarity predictors (Spec2Vec and MS2Deepscore) as well as detected precursor masses to rank potential analogues and exact matches. Benchmarking MS2Query on reference mass spectra and experimental case studies demonstrate improved reliability and scalability. Thereby, MS2Query offers exciting opportunities to further increase the annotation rate of metabolomics profiles of complex metabolite mixtures and to discover new biology.

Indexed as

Machine LearningMetabolomicsComplex MixturesMass SpectrometryReproducibility of ResultsComplex Mixtures

Identifiers

PMID36990978
PMCPMC10060387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.